Restanza's New Hope: Advance Life Sciences To Conduct New Pivotal Trials
This article was originally published in The Pink Sheet Daily
Executive Summary
Company sees options in recommendations from FDA advisory committees for community-acquired bacterial pneumonia and for use of animal efficacy rule for biodefense indications.